Those Most in Need Least Likely to Get Newer Diabetes Medications Those Most in Need Least Likely to Get Newer Diabetes Medications

Racial and socioeconomic disparities may be impeding access to newer diabetes medications, including DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors, among US patients.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news